Skip to content

Effects of Propofol-Induced Anaesthesia on the ST-segment of the ECG

Effects of Propofol-Induced Anaesthesia on the ST-segment of the ECG

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05185401
Acronym
Prop ST
Enrollment
500
Registered
2022-01-11
Start date
2022-02-28
Completion date
2022-04-30
Last updated
2022-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No Specific Condition (Patients Without Brugada Syndrome)

Brief summary

The purpose of this study is to assess the effect of propofol induced general anaesthesia on the ST-segment of the electrocardiogram. This will be realised by retrospectively analysing the ECG-recordings from adult patients undergoing any treatment at the Catheterisation Laboratory. The ST-segment and other ECG measurements from induction of anaesthesia up to 20 minutes later, will be assessed and compared to the baseline values of the respective segments acquired before injecting propofol. It is essential in this study to exclude any patients burdened with the diagnosis, suspicion or family history of Brugada syndrome.

Interventions

OTHERObservational study

Retrospective data-analysis

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Induction of anaesthesia with propofol * Monitored anaesthesia in the CathLab of the Universitair Ziekenhuis Brussel

Exclusion criteria

* Brugada Syndrome or family history of Brugada syndrome * Paediatric population (age \<18) * Patients who did not receive propofol during the procedure * Patients who presented with fever (central core temperature \>38,0°C)

Design outcomes

Primary

MeasureTime frameDescription
ST-segment variations after propofol administration.Baseline ECG will be measured before administration of propofol. ECG will be measured in the 20 minutes following administration of propofolDetermine ST-segment variations in mm (either augmentation or suppression) on the ECG in the 20 minute period after administration of propofol in comparison to the baseline ECG

Secondary

MeasureTime frameDescription
Additional ECG-segment variations after propofol administrationBaseline ECG will be measured before administration of propofol. ECG will be measured in the 20 minutes following administration of propofolAssess additional ECG-segments measurements in mm and ms from the ECGs recorded. These include Jp- (mm), QRS- (ms), T(p-e)-segments (ms) and the T(p-e)/QT ratio.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026